83% of COVID patients who died in Delhi had co-morbidity: Arvind Kejriwal

▴ Delhi Chief Minister Arvind Kejriwal
Delhi Cheif Minister Arvind Kejriwal said that 83% of the COVID-19 patients who died had co-morbidity

Delhi Chief Minister Arvind Kejriwal on Tuesday said "We have found that 83 per cent of patients who have died had co-morbidity which me ans serious medical conditions like sugar, blood pressure, kidney disease, cancer etc," he said.
Kejriwal said the government has analysed the deaths due to COVID-19 in Delhi.
"We found that in 80 per cent of the cases the patients were above 50 years old and only 20 per cent were below 50 years. This shows that senior citizens are more at risk.
"We have received reports that in many states the journalists were found positive with COVID-19. Journalists are working in the frontline in this extraordinary time and I salute their courage. This is the time when people need proper information and by risking their life journalists are working round the clock."
From Wednesday, the government will open a centre where any journalist can visit for COVID-19 test.
"I wish no journalist will be found positive with COVID-19 and stay in good health," said Kejriwal.
"As much as 431 people have recovered so far and went back home, 47 people have died and we have 1,603 active cases. On Monday, we collected 1,397 samples which means nearly 1,400 samples and only 78 cases were found positive," said Kejriwal.
Kejriwal also mentioned that to accommodate more people if the number of cases increases the Delhi government has also ordered 60 new ambulances.
Delhi's COVID-19 patient count reached more than 2,150 on Tuesday.

Tags : #Delhi #Positivecases #COVID-19 #Cheifminister #ArvindKejriwal

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

KIMS Hospitals Takes Another Major Step Forward in Cancer Care with Advanced TrueBeam TechnologyNovember 04, 2026
SRM Medical College Hospital and Research Centre Hosts National Conference on Translational Regenerative Biology and Bioengineering – TRBB 2026November 04, 2026
15-Month-Old Russian Baby Avoids Lung Transplant Following Treatment at MGM HealthcareNovember 04, 2026
Why Diabetes Care Must Go Beyond Blood Sugar ControlNovember 04, 2026
Sri Sathya Sai Heart Hospital Successfully Organises Free Heart Camp, Screening for 550 Patients in Dehradun, UttarakhandNovember 04, 2026
Expert Quote | Rising Air Pollution in Delhi | Agilus DiagnosticsNovember 04, 2026
Healthcare AI Safety Officers: India's New Leadership NeedNovember 04, 2026
Next-Generation Medical Imaging: Beyond Traditional ScansNovember 04, 2026
Menopause Care in India: Building Awareness Beyond Reproductive YearsNovember 04, 2026
Endometriosis in India: Why Diagnosis and Care Coordination MatterNovember 04, 2026
Newborn Screening in India: What Families Should Know About Early TestsNovember 03, 2026
Organ Donation in India: How the Transplant Coordination Journey WorksNovember 03, 2026
Digitising CSSD Instrument Tracking Across Hospital Sterilisation CyclesNovember 03, 2026
How Hospitals Can Audit AI Tools Before DeploymentNovember 03, 2026
Microfluidics in Healthcare: Why Tiny Technology Could Have a Huge ImpactNovember 03, 2026
Evaluating CTEPH: V/Q Scans, Right Heart Catheterization, & Pulmonary EndarterectomyNovember 02, 2026
Interleukin Inhibitors vs Traditional Systemics in Resistant PsoriasisNovember 02, 2026
The Role of Community Pharmacies in Healthcare AccessNovember 02, 2026
How Diagnostic Networks Can Support Timely Referral DecisionsNovember 02, 2026
Health Insurance for India's Gig Economy: What Must ChangeNovember 02, 2026